JosephKHofmeisterMD
Oncology • Columbus, OHGastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer
Currently practicing hematology and oncology at Columbus Oncology and Hematology and CMO of Dr. Joe Explains. Dr. Joe Explains is the medical education expert focused on understanding and activation. We put a new, creative spin on the meaning of medical information, transforming complex medical topics into understandable concepts, and preparing patients for their healthcare journey.
Dr. Hofmeister is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
810 Jasonway Ave
Columbus, OH 43214Phone+1 614-442-3130Fax+1 614-442-3145
Summary
- Dr. Joseph Hofmeister is an oncologist at Columbus Oncology and Hematology in Columbus, OH and is affiliated with OhioHealth Riverside Methodist Hospital. He received his medical degree from the University of Pittsburgh School of Medicine and has been in practice 20 years. He specializes in many cancers including thoracic oncology, and gastrointestinal cancer. He also is experienced in benign hematology and hematologic oncology. His passion is creating customized patient health resources as a co-founder and CMO of Dr. Joe Explains.
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1997 - 2000
UPMC Medical EducationResidency, Internal Medicine, 1995 - 1997- UPMC Medical Education/MercyInternship, Internal Medicine, 1994 - 1995
University of Pittsburgh School of MedicineClass of 1994
Certifications & Licensure
OH State Medical License 1997 - 2026
PA State Medical License 1995 - 1998
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Skip Weiler Inspirational Award Cancer Support Community Central Ohio, 2018
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 62 citationsets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.James L. Smith, Alicia Erbe Schaffner, Joseph K. Hofmeister, Matthew Hartman Hartman, Guo Wei
Molecular and Cellular Biology. 2000-11-01 - 184 citationsClustered CD20 Induced Apoptosis: Src-Family Kinase, the Proximal Regulator of Tyrosine Phosphorylation, Calcium Influx, and Caspase 3-Dependent Apoptosis☆☆☆★Joseph K. Hofmeister, Damon S. Cooney, K. Mark Coggeshall
Blood Cells, Molecules & Diseases. 2000-04-01
Books/Book Chapters
Authored Content
- Is Cancer a Battle We Win or Lose?3/8/2018
Press Mentions
OhioHealth to Build New Comprehensive Outpatient Cancer CenterDecember 11th, 2024
Examples Help Breast Cancer Patients UnderstandMarch 31st, 2017
Professional Memberships
- Member
External Links
- Dr. Joe Explainshttps://drjoeexplains.com/
- Dr. Joe Explains Facebook Page https://www.facebook.com/DrJoeExplains/?ref=page_internal
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
